SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-097430
Filing Date
2016-02-10
Accepted
2016-02-10 18:45:07
Documents
2
Period of Report
2016-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3605
2 POA DOCUMENT poa.txt EX-24.3_631790 3624
  Complete submission text file 0001209191-16-097430.txt   8653
Mailing Address C/O SOMAXON PHARMACEUTICALS, INC. 3721 VALLEY CENTRE DRIVE, SUITE 500 SAN DIEGO CA 92130
Business Address
LITALIEN JAMES J (Reporting) CIK: 0001182613 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37693 | Film No.: 161407210

Mailing Address 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015
Business Address 2275 HALF DAY ROAD SUITE 160 BANNOCKBURN IL 60015 972-725-7797
AveXis, Inc. (Issuer) CIK: 0001652923 (see all company filings)

IRS No.: 901038273 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)